TRES CANTOS OPEN LAB FOUNDATION

Registered charity 1142577 · accounts filings on the Charity Commission register

TO FUND AND SUPPORT RESEARCH AT, OR IN COLLABORATION, WITH GSK'S R&D FACILITIES IN TRES CANTOS, SPAIN INTO MEDICINES FOR DISEASES OF THE DEVELOPING WORLD (INCLUDING, BUT NOT LIMITED TO MALARIA, TUBERCULOSIS, AND OTHER NEGLECTED DISEASES WHICH ARE IDENTIFIED BY THE CHARITY FROM TIME TO TIME).

Causes: The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts

Latest income
£952k
Latest spending
£1.8m
Registered
2011
Accounts read
FY2024

Financial health, per its FY2024 accounts

The accounts state that the charity held unrestricted reserves of £2,080,329 at the end of the year, a decrease from £2,884,259 in the prior year. The charity reported a net expenditure deficit of £803,930 for the year, funded by incoming resources of £951,586. The trustees confirmed the charity is a going concern with sufficient cash resources to cover committed projects and expenses for the next 1.5 years.

Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: circa £500k per year (held: £2.1m)
“The Directors set a target to have a level of free reserves to be able to fund future grants and meet the general running costs, which are usually an amount of circa £500k per year.” — page 8
Per its FY2024 accounts as filed with the Charity Commission.
Related-party transaction: Donated services in kind from GSK/GGL
“In the year Glaxo Group Limited provided £657,685 (2023: £454,901) of donated services to the Charity in the form of staff time spent on TCOLF activities.” — page 25
“During the year to 31 December 2024 TCOLF incurred fees payable to GSK amounting to £135,419 (2023: £148,031).” — page 25
Per its FY2024 accounts as filed with the Charity Commission.
Related-party transaction: Fees payable to GSK
“In the year Glaxo Group Limited provided £657,685 (2023: £454,901) of donated services to the Charity in the form of staff time spent on TCOLF activities.” — page 25
“During the year to 31 December 2024 TCOLF incurred fees payable to GSK amounting to £135,419 (2023: £148,031).” — page 25
Per its FY2024 accounts as filed with the Charity Commission.

Accounts audited by RSM UK Audit LLP. Discloses 5 of 6 completeness components.

Corporate structure

Company officers (Companies House)

Current officers of the charity’s own company per the Companies House register, cross-checked against the Charity Commission trustee list by name. A director not on the trustee list is usually a timing or naming difference between the two registers — check both records before drawing conclusions.

Official officers record.

Structured financials (annual return, FY ending 31/12/2024)

Total income
£952k
Total spending
£1.8m
Reserves (reported)
£2.1m
Employees
0

Reported reserves equal ~14.2 months of spending — in the top quarter for charities its size (median 5.2 months; benchmarks).

Per its annual return, largest income source: Donations and legacies (69% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 0.0% of total income — below the median for charities its size (4.9%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Spain

Income and spending

Financial year endIncomeSpending
31/12/2024£952k£1.8m
31/12/2023£737k£1.5m
31/12/2022£343k£2.4m
31/12/2021£5.3m£1.3m
31/12/2020£324k£2.6m

Common questions

Is TRES CANTOS OPEN LAB FOUNDATION financially healthy?

Per its FY2024 accounts: The accounts state that the charity held unrestricted reserves of £2,080,329 at the end of the year, a decrease from £2,884,259 in the prior year. The charity reported a net expenditure deficit of £803,930 for the year, funded by incoming resources of £951,586. The trustees confirmed the charity is a going concern with sufficient cash resources to cover committed projects and expenses for the next 1.5 years. Its FY2024 accounts were audited by RSM UK Audit LLP.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with MALARIA CONSORTIUM.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
TRES CANTOS OPEN LAB FOUNDATION£952k—0unclear—no doubt
MALARIA CONSORTIUM FY2025£72.2m——above—no doubt
THE YUSUF AND FARIDA HAMIED FOUNDATION FY2023£7.3m—0unclear—no doubt
WANDSWORTH OASIS TRADING COMPANY LIMITED FY2026£1.1m—0unclear—no doubt
THE INTERNATIONAL CML FOUNDATION FY2025£267k£80,001 - £90,0001unclear13.0%no doubt
STOCKPORT NHS FOUNDATION TRUST GENERAL FUND FY2025£930k—0above—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.